Leukemia Clinical Trials in Dallas

Showing 861-880 of 1,246 trials

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

NCT03121144

This study describes a procedure to collect a subject's position, movement, physiological data and usability information using Masimo's investigational device.

Pressure UlcerPressure InjuryFalls Injury

Masimo Corporation34 participantsStarted Mar 2017

Dallas, Texas, United States

COMPLETEDPhase 2< 1 mile

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01154816

This phase II trial is studying the side effects of and how well alisertib works in treating young patients with relapsed or refractory solid tumors or leukemia. Alisertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Acute Lymphoblastic Leukemia+8 more

Children's Oncology Group118 participantsStarted Feb 2011

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Little Rock, Arkansas, United States +102 more locations

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Leukemia Trials in Other Cities

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

Study Comparing OsseoSpeed™ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw

Other Conditions in Dallas